InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Handley Michael K, Chairman & CEO. Officer active across 1 companies, notably Cytocom, Inc.. Aggregated, 2 reports have been logged. The latest transaction was disclosed on 27 July 2021 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
0296,609 shares0
Common Stock, par value $0.005 per share
SEC:0001437749-21-018563·
0296,609 shares0
Common Stock, par value $0.005 per share
SEC:0001437749-21-018563:0·
2 of 2 declarations
About Handley Michael K
Michael K. Handley is the President and CEO of Cytocom, Inc. He leads the company with a strategic vision focused on innovation and growth. Handley brings significant expertise in business management and product development, thus contributing to Cytocom's mission to provide advanced therapeutic solutions. His leadership is essential for navigating the dynamic biotechnology market.
